Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedVersion 92 was added to the history on 2026-09-25 with a Study Status update. An older entry dated 2026-08-28 was removed.SummaryDifference0.2%

- Check14 days agoChange DetectedA new Revision: v3.7.0 entry was added to the Record History, replacing the previous v3.6.6 entry. This records a page update in the study’s history.SummaryDifference0.0%

- Check35 days agoChange DetectedA new history entry dated 2026-08-28 with the Study Status was added, introducing revision v3.6.6; the older entry dated 2026-07-31 with revision v3.6.5 was removed.SummaryDifference0.2%

- Check42 days agoChange DetectedA References section has been added to the study record history, providing citations and sources for the study updates. This addition helps users locate supporting materials linked to prior submissions.SummaryDifference0.1%

- Check56 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5, indicating a minor site software release. This update does not modify any study data or the history records displayed on the page.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a new version entry on 2026-07-31 with a Study Status note linked to 2026-07-30 and the value 90. Removed the 2026-07-13 entry from the history.SummaryDifference0.2%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.